INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PT

Power Luke Thomas

See RemarksCIK 0002072013

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 2
Max Insider Score22
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Tax withholding
F$149K
9,771 sh
May 15, 2026May 18, 2026
traded May 15, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Caris Life Sciences, Inc.See Remarks · Dec 12, 2025
17
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Grant or award
A
—
64.0K sh
Mar 6, 2026
Mar 10, 2026
traded Mar 6, 2026
+4d
SEC FORM 4

Evidence

22
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Open-market sale · 10b5-1 plan
SELL$1.62M
60.9K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

5
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,400 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
24.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

10
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M$92K
37.5K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

10
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M$60K
24.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence